Arjona Ferreira | Merck Sharp And Dohme Corp. A Subsidiary Of Merck And Co. Inc.
スポンサーリンク
概要
- ARJONA FERREIRA Juan Camiloの詳細を見る
- 同名の論文著者
- Merck Sharp And Dohme Corp. A Subsidiary Of Merck And Co. Inc.の論文著者
関連著者
-
Kadowaki Takashi
Department Of Cardiovascular Medicine Graduate School Of Medicine University Of Tokyo
-
TAJIMA Naoko
Jikei University School of Medicine
-
Arjona Ferreira
Merck Sharp And Dohme Corp. A Subsidiary Of Merck And Co. Inc.
-
TANIGUCHI Tadaaki
MSD K. K.
-
ODAWARA Masato
The Third Department of Internal Medicine, Tokyo Medical University
-
NISHII Mikio
Ono Pharmaceutical Co., Ltd.
-
Nishii Mikio
Ono Pharmaceutical Co. Ltd.
-
Kadowaki Takashi
Department Of Diabetes And Metabolic Diseases Graduate School Of Medicine The University Of Tokyo
-
Odawara Masato
The Third Department Of Internal Medicine Tokyo Medical University
-
Kadowaki Takashi
Department Of Cardiology Kawasaki Medical School
-
Odawara Masato
Department Of Endocrinology And Metabolism Toranomon Hospital
-
NISHII Mikio
Global Clinical Development, Ono Pharmaceutical Co., Ltd.
-
Odawara Masato
Department Of Diabetes Endocrinology And Metabolism Tokyo Medical University
著作論文
- Long-term safety, tolerability, and efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes
- Addition of sitagliptin to ongoing glimepiride therapy in Japanese patients with type 2 diabetes over 52 weeks leads to improved glycemic control